Atlas Trials

Injection Regimen Trial of PEG-rhG-CSF During Breast Cancer Chemotherapy

Clinical trial NCT04477616 · COMPLETED

Trial details

NCT number
NCT04477616
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2021-07-13
Primary completion
2022-10-06
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.